Actively Recruiting

Phase 2
Phase 3
Age: 18Years - 60Years
All Genders
NCT06068179

Graves' Disease Remission Study: MycoMeth Combo

Led by The First Affiliated Hospital of Xiamen University · Updated on 2024-02-28

205

Participants Needed

1

Research Sites

155 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

A randomized study to evaluate the efficacy and safety of combining mycophenolate mofetil with methimazole in patients with newly diagnosed Graves' disease.

CONDITIONS

Official Title

Graves' Disease Remission Study: MycoMeth Combo

Who Can Participate

Age: 18Years - 60Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Aged 18 to 60 years.
  • Newly diagnosed with Graves' disease.
Not Eligible

You will not qualify if you...

  • Previously treated for Graves' disease or experienced relapse.
  • Hyperthyroidism caused by other conditions such as toxic multinodular goiter, toxic thyroid adenoma, Hashimoto's thyroiditis, subacute thyroiditis, or iodine-induced hyperthyroidism.
  • Needing treatment for moderate to severe thyroid eye disease at enrollment.
  • Hyperthyroidism requiring surgery due to thyroid cancer.
  • Severe liver or kidney dysfunction (ALT or AST more than 3 times normal, creatinine above 135 mol/L for males or 110 mol/L for females).
  • Leukopenia (white blood cell count below 3.0×10^9/L).
  • Severe heart failure (New York Heart Association class III or IV).
  • Chronic or severe infections like pulmonary tuberculosis or hepatitis B.
  • Pregnant, breastfeeding, planning pregnancy soon, or unable to use contraception during the trial.
  • Participation in other clinical studies currently or previously.
  • Unwilling or unable to comply with follow-up or participate in the study.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Xiao Fangsen

Xiamen, Fujian, China, 361003

Actively Recruiting

Loading map...

Research Team

F

Fangsen Xiao, MD

CONTACT

L

Liyin Wang, MM

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here